Immucell (ICCC) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$62319.0.
- Immucell's Other Operating Expenses changed N/A to -$62319.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 5355.99%. This contributed to the annual value of $3.5 million for FY2024, which is 84927.85% up from last year.
- According to the latest figures from Q3 2025, Immucell's Other Operating Expenses is -$62319.0.
- Over the past 5 years, Immucell's Other Operating Expenses peaked at $992556.0 during Q4 2022, and registered a low of -$62319.0 during Q3 2025.
- In the last 5 years, Immucell's Other Operating Expenses had a median value of $436982.0 in 2021 and averaged $428451.8.
- Data for Immucell's Other Operating Expenses shows a peak YoY increase of 981640.18% (in 2024) and a maximum YoY decrease of 1900519.48% (in 2024) over the last 5 years.
- Quarter analysis of 5 years shows Immucell's Other Operating Expenses stood at $889929.0 in 2021, then rose by 11.53% to $992556.0 in 2022, then fell by 17.64% to $817486.0 in 2023, then grew by 2.28% to $836147.0 in 2024, then plummeted by 107.45% to -$62319.0 in 2025.
- Its last three reported values are -$62319.0 in Q3 2025, $7128.0 for Q2 2025, and $426587.0 during Q1 2025.